WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO2018047036) METHOD OF AMELIORATING OR PREVENTING THE WORSENING OR THE PROGRESSION OF SYMPTOMS OF BPH
Latest bibliographic data on file with the International Bureau    Submit observation

Pub. No.:    WO/2018/047036    International Application No.:    PCT/IB2017/055187
Publication Date: 15.03.2018 International Filing Date: 29.08.2017
IPC:
A61K 38/10 (2006.01), A61P 13/08 (2006.01), A61K 31/18 (2006.01), A61K 31/473 (2006.01), A61K 31/4985 (2006.01), A61K 31/505 (2006.01), A61K 31/517 (2006.01), A61K 31/58 (2006.01)
Applicants: NYMOX CORPORATION [US/US]; 777 Terrace Avenue Hasbrouck Heights, NJ 07604 (US)
Inventors: AVERBACK, Paul; (BS)
Agent: DOODY, Patrick A.; Pillsbury Winthrop Shaw Pittman LLP P.O. Box 10500 McLean, VA 22102 (US)
Priority Data:
15/258,786 07.09.2016 US
Title (EN) METHOD OF AMELIORATING OR PREVENTING THE WORSENING OR THE PROGRESSION OF SYMPTOMS OF BPH
(FR) PROCÉDÉ D'AMÉLIORATION OU DE PRÉVENTION DE L'AGGRAVATION OU DE LA PROGRESSION DE SYMPTÔMES DE HBP
Abstract: front page image
(EN)The embodiments include methods of ameliorating or preventing the worsening or progression and/or ameliorating or preventing the worsening or lack of improvement of symptoms of BPH in mammals, using compositions containing compounds based on small peptides and a pharmaceutically acceptable carrier. The method includes, but is not limited to, administering the compounds intramuscularly, orally, intravenously, intraprostatically, intrathecally, intratumorally, intranasally, topically, transdermally, etc., either alone or conjugated to a carrier to a mammal in need thereof.
(FR)Les modes de réalisation de la présente invention comprennent des procédés d'amélioration ou de prévention de l'aggravation ou la progression et/ou d'amélioration ou de prévention de l'aggravation ou de l'absence d'amélioration des symptômes d'hyperplasie bénigne de la prostate (HBP) chez les mammifères, au moyen de compositions contenant des composés à base de petits peptides et un support pharmaceutiquement acceptable. Le procédé comprend, sans limitation, l'administration des composés par voie intramusculaire, orale, intraveineuse, intraprostatique, intrathécale, intratumorale, intranasale, topique, transdermique, etc., seuls ou conjugués à un support, à un mammifère nécessitant un tel traitement.
Designated States: AE, AG, AL, AM, AO, AT, AU, AZ, BA, BB, BG, BH, BN, BR, BW, BY, BZ, CA, CH, CL, CN, CO, CR, CU, CZ, DE, DJ, DK, DM, DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, HR, HU, ID, IL, IN, IR, IS, JO, JP, KE, KG, KH, KN, KP, KR, KW, KZ, LA, LC, LK, LR, LS, LU, LY, MA, MD, ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, PA, PE, PG, PH, PL, PT, QA, RO, RS, RU, RW, SA, SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, TH, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW.
African Regional Intellectual Property Organization (BW, GH, GM, KE, LR, LS, MW, MZ, NA, RW, SD, SL, ST, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, RU, TJ, TM)
European Patent Office (AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, KM, ML, MR, NE, SN, TD, TG).
Publication Language: English (EN)
Filing Language: English (EN)